CRESCENT BIOPHARMA, INC. Common Stock, Capital Shares Reserved for Future Issuance
CRESCENT BIOPHARMA, INC. (CBIO) had Common Stock, Capital Shares Reserved for Future Issuance of 15.96 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-07-30
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 15.96M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 16.14M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 14.12M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 12.34M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 15.96M shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 16.14M shares 10-Q · filed 2026-04-29 |
| 2025-12-31 | 14.12M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 12.34M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 12.34M shares 10-Q · filed 2025-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |